Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allopurinol (zyloprim) (1 trial)
terbinafine (lamisil) (1 trial)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Diabetic Nephropathies (Phase 3)
Kidney Diseases (Phase 3)
Myocardial Ischemia (Phase 3)
Trials (2 total)
Trial APIs (2 total)